Primarily evaluated as potentially resectable and conversed successfully
Adequate hematologic function: absolute neutrophil count (ANC)≥1.5×109/l, platelets≥75×109/l, and international normalized ratio (INR) ≤1.3 (within 1 week prior to randomization)
Adequate liver and renal function: total bilirubin ≤2.0 mg/dl, alanine aminotransferase, aspartate aminotransferase ≤ 5x upper limit of normal, and albumin≥2.5 g/dl, serum creatinine≤2.0 mg/dl (within 1 week prior to randomization);
Written informed consent for participation in the trial.
You may not be if
Primarily evaluated as resectable
Failed to converse
Patients with known hypersensitivity reactions to any of the components of the study treatments.
Pregnancy (absence confirmed by serum/urine β-HCG) or breast-feeding
Other previous malignancy within 5 years
Known drug abuse/ alcohol abuse
Legal incapacity or limited legal capacity
Clareo Health | Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis
